• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

    18.72 -0.15 (-0.79%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 445,683
    Open 18.90
    Bid (Size) 18.71 (700)
    Ask (Size) 18.73 (3,500)
    Prev. Close 18.87
    Today's Range 18.50 - 19.12
    52wk Range 16.64 - 31.26
    Shares Outstanding 48,081,433
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    3 Stocks Under $50 We Keep Off Our Radar
    Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However... 
    Via StockStory
    Topics Energy
    Amphastar Pharmaceuticals (NASDAQ:AMPH) Screens as a High-Quality Stock with Deep Value Appeal ↗
    Via Chartmill

    Performance

    YTD
    -29.3%
    -29.3%
    1 Month
    -4.1%
    -4.1%
    3 Month
    -10.9%
    -10.9%
    6 Month
    -28.4%
    -28.4%
    1 Year
    -17.3%
    -17.3%

    More News

    Read More
    News headline image
    1 of Wall Street’s Favorite Stocks to Research Further and 2 Facing Challenges
    Via StockStory
    News headline image
    1 Healthcare Stock to Consider Right Now and 2 We Brush Off
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth ↗
    Via MarketBeat
    Amphastar (AMPH) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Amphastar Pharmaceuticals (NASDAQ:AMPH) Q1 Results Miss Estimates, Stock Slides After Hours ↗
    Via Chartmill
    News headline image
    Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag ↗
    Via MarketBeat
    News headline image
    Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
    Via ACCESS Newswire
    News headline image
    3 Stocks Under $50 with Open Questions
    Via StockStory
    News headline image
    Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today
    Via StockStory
    News headline image
    Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook ↗
    Via MarketBeat
    News headline image
    The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 CY2026 Sales Expectations, Stock Drops
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals (AMPH) To Report Earnings Tomorrow: Here Is What To Expect
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down
    Via StockStory
    News headline image
    Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026
    Via ACCESS Newswire
    News headline image
    Why Amphastar Pharmaceuticals (AMPH) Shares Are Sliding Today
    Via StockStory
    Topics Economy
    News headline image
    Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q4 Earnings?
    Via StockStory
    Topics Stocks Supply Chain
    News headline image
    Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    1 Healthcare Stock to Target This Week and 2 We Avoid
    Via StockStory
    News headline image
    Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
    Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
    What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
    The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 18.72
    When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 07/24/26 04:00 PM ET
    What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 900.08M
    How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
    Amphastar Pharmaceuticals, Inc. - Common Stock has 900M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.